Chidambaran Ramachandran

Title: Innovations of Chidambaran Ramachandran in Biochemical Assays

Introduction

Chidambaran Ramachandran is a notable inventor based in Pierrefonds, CA. He has made significant contributions to the field of biochemistry, particularly in the development of assays for proteases and phosphatases. His innovative work has implications for various medical conditions, including diabetes and cancer.

Latest Patents

Ramachandran holds a patent for a "Prosphatase binding assay." This invention discloses a binding assay for proteases and phosphatases that contain cysteine in their binding sites. The assay utilizes the nucleophilic properties of the sulfhydryl group in cysteine to determine the binding ability of new ligands against known enzyme inhibitors. By employing a mutant form of the enzyme, the assay effectively mitigates interference from oxidizing and alkylating agents, enhancing its reliability. This assay has important applications in drug discovery for diseases such as Alzheimer's and osteoporosis.

Career Highlights

Chidambaran Ramachandran is associated with Merck Frosst Canada & Co., where he has been instrumental in advancing biochemical research. His work has not only contributed to the scientific community but has also paved the way for new therapeutic approaches in medicine.

Collaborations

Ramachandran has collaborated with notable colleagues, including Richard W. Friesen and Michael Gresser. These partnerships have further enriched his research and development efforts in the field of biochemistry.

Conclusion

Chidambaran Ramachandran's innovative contributions to biochemical assays exemplify the impact of scientific research on healthcare. His patented work continues to influence the discovery of new treatments for various diseases.